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Background: The integration of digital treatments into national mental health services is on the agenda in the Eu-
ropean Union. The E-COMPARED consortium conducted a survey aimed at exploring stakeholders' knowledge,
acceptance and expectations of digital treatments for depression, and at identifying factors that might inﬂuence
their opinions when considering the implementation of these approaches.
Method: An online survey was conducted in eight European countries: France, Germany, Netherlands, Poland,
Spain, Sweden, Switzerland and The United Kingdom. Organisations representing government bodies, care pro-
viders, service-users, funding/insurance bodies, technical developers and researchers were invited to participate
in the survey. The participating countries and organisations reﬂect the diversity in health care infrastructures and
e-health implementation across Europe.
Results: A total of 764 organisations were invited to the survey during the period March–June 2014, with 175 of
these organisations participating in our survey. The participating stakeholders reported moderate knowledge of
digital treatments and considered cost-effectiveness to be the primary incentive for integration into care services.
Low feasibility of deliverywithin existing care serviceswas considered to be a primary barrier. Digital treatments
were regardedmore suitable for milder forms of depression. Stakeholders showed greater acceptability towards
blended treatment (the integration of face-to-face and internet sessions within the same treatment protocol)
compared to standalone internet treatments. Organisations in countries with developed e-health solutions re-
ported greater knowledge and acceptability of digital treatments.
Conclusion: Mental health stakeholders in Europe are aware of the potential beneﬁts of digital interventions.
However, there are variations between countries and stakeholders in terms of level of knowledge about such in-
terventions and their feasibility within routine care services. The high acceptance of blended treatments is an in-
teresting ﬁnding that indicates a gradual integration of technology into clinical practicemay ﬁt the attitudes and
needs of stakeholders. The potential of the blended treatment approach, in terms of enhancing acceptance of dig-
ital treatment while retaining the beneﬁt of cost-effectiveness in delivery, should be further explored.
Funding: The E-COMPARED project has received funding from the European Union Seventh Framework Pro-
gramme (FP7/2007–2013) under grant agreement no. 603098.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Depression is currently a leading cause of years lived with disability
(YLD) in 146 countries (Vos et al., 2015) andMajor Depressive Disorder
is expected to become the greatest contributor to the global burden of
disease (WHO, 2008). Treatment resources are insufﬁcient and it is an
international priority to increase the coverage of interventions for de-
pression (WHO, 2013).
Experts emphasize that the digital technology has the potential to
improve access to care for mental disorders (Andersson, 2016). Dig-
ital psychological interventions are under development and testing
in Australia (Perini et al., 2009), Canada (Hadjistavropoulos et al.,
2016), The United States (Andersson, 2016; Mohr et al., 2013) and
a range of European countries (Andersson et al., 2005; Berger et al.,
2011; Buntrock et al., 2016; O'Mahen et al., 2014; Ruwaard et al.,
2009). The digital treatment approach involves adapting standard
face-to-face protocols into computerised self-help material that is
delivered over a set time period either as pure self-help program or
alongside brief therapist support. In this way the treatments become
highly automated and geographically independent, which positively
impact therapist capacity and patient access. Currently, digital pro-
grams that are based on Cognitive Behavioural Therapy (internet-
based CBT or ICBT) have been evaluated in N100 controlled trials
with promising results for several mental and somatic disorders
(Andersson, 2016). The reported clinical effects for therapist-sup-
ported ICBT for depression are large and stable over a number of tri-
als (Cuijpers et al., 2015). In direct comparison to face-to-face
treatment effect sizes are similar (Andersson et al., 2014;
Andersson et al., 2016). A relatively newly developed but increasing-
ly applied route in the ﬁeld of digital treatment is ‘blended treat-
ment’ (BT) (Wentzel et al., 2016). In this approach self-help
material is blended with face-to-face sessions (reduced in number
compared to standard treatment) (Kleiboer et al., 2016). The blend-
ed treatment emphasises the integration of standard and digitalized
modalities and the advantages this brings for both the therapist and
the patient. Face-to-face sessions enable more extensive therapist
support and improved monitoring of the patient's wellbeing in com-
parison to standalone ICBT. As the standardized parts of treatment
are delivered online it also means that sessions can be used to ad-
dress and tailor the treatment to individual patient's needs. The stan-
dardized components can be delivered online, which for the patient
means unlimited access to treatment and less demands in terms of
travel and costs (Romijn et al., 2015). It has been suggested that BT
can be an alternative to ICBT (the most common treatment for mild
to moderate depression), for example in specialized treatment ser-
vices and for patients with more severe symptomatology (Kleiboer
et al., 2016). Examples of BT designs that have been evaluated with
promising result are unguided self-help reading material combined
with face-to-face sessions, and digital therapy as a partial replace-
ment of face-to-face sessions (Ly et al., 2015; Wentzel et al., 2016).
In some countries like Australia, Canada and Sweden there are ex-
amples of ICBT programmes being transferred from research settings
into utilisation within regular care services (Andersson and Hedman,
2013; Hadjistavropoulos et al., 2014; Titov et al., 2016). An integra-
tion of ICBT treatment into national health services is now on the
agenda in the European Union (Vis et al., 2015). This is reﬂected in
several ongoing European research and funding programs (E-COM-
PARED, Joint action and Wellbeing, Horizon 2020). Effectiveness-re-
search to establish clinical and cost-beneﬁts of ICBT in real world
settings has been conducted (e.g. Hadjistavropoulos et al., 2014;
Hedman et al., 2014; Ruwaard et al., 2012; Titov et al., 2016) and is
currently researched in different European settings (Kemmeren et
al., 2016; Kleiboer et al., 2016). Therefore, it is of importance to as-
sess the views of all stakeholders that would be directly involved
or affected by the implementation of ICBT treatments such as gov-
ernment bodies, care providers, professionals, patients and funders.
Limited research exists that investigates current knowledge, atti-
tudes and expectations of digital treatment. This survey was con-
ducted with the aim to explore European mental health care
stakeholders' knowledge and acceptance of ICBT and BT, and their
expectations when considering integration of digital treatments
into regular care services. The survey was conducted in the context
of the wider research project E-COMPARED, that was initiated to
provide mental healthcare stakeholders with evidence-based infor-
mation about the clinical and cost-effectiveness of digital treatments
for depressive disorders.
2. Material and methods
2.1. Background
This studypresentsﬁndings on European stakeholders' self-reported
knowledge and attitudes towards ICBT and BT in treatment of adult de-
pression. The results derive from a European online survey that was
conducted by the E-COMPARED project between March to June 2014.
Six survey items that assessed stakeholders' views on ICBT and BT
were selected to be discussed in this paper. The original survey was
more comprehensive and also assessed views on standard pharmaco-
logical and therapeutic treatments for adult depression. The survey in
its full length can be found in Appendix 2.
2.2. Survey development and design
No prior surveys existed on stakeholder's views on standard
treatments and digital treatments for depression, therefore this sur-
vey was conducted by the E-COMPARED consortium. Initially the
consortium jointly developed an English version of the survey, there-
after consortium members translated the survey into their ﬁrst lan-
guages (French, German, Dutch, Polish, Spanish, Swedish).
Consortium members that adapted the survey were involved in the
development of the original version and the process did not include
formal back-translation.
The full survey was comprised of 40 questions that assessed views
on standard treatments and novel digital treatments (ICBT and BT) on
adult depression. The survey covered four thematic areas: i) knowledge
of treatments, ii) attitudes towards treatments, iii) acceptability (rec-
ommendation) of treatments and iiii) near future expectations of treat-
ments. The survey questions were presented in the form of six-point
scales (0–5), yes/no options and as ranking alternatives. Beyond stan-
dard response options the survey allowed free text comments and the
alternative “not applicable”. ICBT and BTwere not expected to be famil-
iar to respondents and these treatments were presented in explanatory
terms. Table 1 shows how the treatment concept and survey questions
on ICBT and BT were presented to participants. See Appendix 1 for orig-
inal survey items. The aim was to optimise understanding (attributing
the samemeaning to the terms) and the validity of the outcome. Partic-
ipants were asked ﬁll out the survey on behalf of their organisation and
to contribute opinions on digital treatment regardless if these treat-
ments were currently accessible in their country.
2.3. Included countries
The surveywas conducted in France, Germany, Netherlands, Poland,
Spain, Sweden, Switzerland and The United Kingdom. The selection of
countries was made a priori to the survey on the basis of the constella-
tion of the E-COMPARED consortium, which in turn was composed to
reﬂect the diversity in Europe in terms of health care infrastructure
and level of e-mental health implementation. A distinction of participat-
ing countries (as ‘frontrunners’, ‘learners’ and ‘followers’) was made a
priori to the survey. The Netherlands, Sweden, and the United Kingdom
(UK) has in relation to other European countries come far in terms of in-
clusion of e-health and presence of digital treatment approaches,
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therefore these countries were considered ‘frontrunners’ in the ﬁeld. In
Germany, Spain and Switzerland, health technologies are currently
evolving and these countries were categorized as ‘follower’ countries.
In France and Poland the current experience and practice of e-health
is limited, and these countries were considered ‘learner’ countries.
2.4. Included stakeholders
The aim was to identify organisations (stakeholders) that were in-
volved in the delivery of depression treatment to the adult population.
In order to identify relevant stakeholders, consortium members com-
piled a list of organisations that were active in the ﬁeld of mental health
care and the organisation categories that were present in all participat-
ing countries were chosen as stakeholders to target for the survey. The
selected stakeholder groups were i) government bodies ii) care pro-
viders and professionals, iii) researchers at universities and institutes,
iv) service funders, v) technology developers/providers of digital ser-
vices within mental health, and vi) organisations representing pa-
tients/users. A description and overview of targeted stakeholder
categories is presented in Fig. 1.
2.5. Recruitment to the survey
Consortiumpartners recruited stakeholders in their respective coun-
try. The recruitment guideline was to recruit at least 1–3 organisations
from each stakeholder category. No higher limit was set. Based on the
stakeholder categories, consortium members identiﬁed organisations
and invited their representatives to participate in the survey via email.
The email brieﬂy presented the E-COMPARED project and the request
to participate in the survey. It contained a link that directed to the online
survey. On the survey start-page the individual was instructed to pro-
vide name and organisation, and to answer the survey on the behalf of
the organisation (and not as an individual agent). Fig. 2 illustrates the
start-page as presented to participants in the survey.
3. Analysis
Five survey items that assessed stakeholder's views on ICBT and BT
were selected for this paper. The survey data was analysed by using de-
scriptive statistics, Kruskal-Wallis tests, χ2 and analysis of variance
(ANOVA). Post-hoc tests were used to test differences in responses
Table 1
Overview of analysed survey items.
Survey theme Presented item Item design
Knowledge of
treatments
(ICBT)
“To what extent does your organisation have knowledge about internet-based psychotherapy
(referred to as online therapy and web-based treatment) as a treatment tool for adult
depression?”
Six-point scale: 0 = no knowledge at all, to 5 = very
good knowledge Opt out option “does not apply”
Attitude towards
treatments (ICBT)
“Is your organisation discussing and/or proclaiming internet-based psychotherapy as a future
enhancement in mental health care?”
Single-choice question: “yes”, “partly”, “no”, “does not
apply”.
Acceptance of
treatments
(ICBT, BT)
“Do you/Would your organisation recommend: 1) stand-alone treatment full psychotherapy
program for computer/tablet/smartphone, with online educational material and communication
with health care professional?” (ICBT)
2) “Traditional face-to-face treatment with the addition of a web-based platform and digital
tools for support, with the aim of reducing the number of face-to-face sessions while
maintaining the same treatment quality” (BT)
Single-choice question: “yes”, “no”, “does not apply”.
Expectations of
treatments
(ICBT)
“What does your organisation expect to be the most important incentive/barrier for integrating
internet-based psychotherapy as a stand-alone treatment for adult depression in your country's
health care system?”
Choose alternative from presented list.
Fig. 1. Targeted stakeholder groups.
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between stakeholder categories and countries (frontrunner countries
versus other countries, Germany versus other countries). The comple-
tion rate varied between items, therefore, sample sizes are continuously
presented.
4. Results
4.1. Enrolment
In total 764 organisations was contacted and 175 returned the ques-
tionnaire, corresponding to a 23% response-rate. The number of targeted
organisations and response rates varied between countries (Poland 29/
300, United Kingdom 4/24, France 4/28, Germany 58/232, Switzerland
13/49, Netherlands 22/77, Sweden 23/31, Spain 22/23), see Fig. 3 for re-
sponse-rates. The participating stakeholders represented all countries
and included 88 organisations in the category of providers and profes-
sionals, 27 government bodies, 26 research institutions (e.g. universities
and institutes), 14 organisations that represented patients/service-users,
11 organisations within service funding and 9 organisations that repre-
sented technology provider/developers. On subgroup level Germany
had most responders (33% of the total sample) and the most well repre-
sented stakeholder group was care providers/professionals (50% of the
total sample). See Table 2 for distributions on country and stakeholder
level. Respondents were evenly distributed between associations operat-
ing on national (38%), regional (34%) and local (28%) level.
4.2. Knowledge
Stakeholders' self-reported knowledge of internet-based treat-
ment for depression is presented in Table 3. Organisations were
asked to indicate their knowledge of any kind of internet-based
psychological treatment even if not currently accessible in their
country. Respondents self-reported their knowledge of digital
treatment (ICBT) on a six-point scale (0–5). The total sample re-
ported a moderate level of knowledge (M = 2.7). There were dif-
ferences between stakeholder categories, with technology
developers reporting higher level of knowledge (M = 4.3) com-
pared to government bodies (M = 1.8) and care providers (M =
2.6) (Tukey p b 0.027–0.001).
Fig. 2. Information on the E-COMPARED survey start page.
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4.3. Activity
Stakeholders' activity on the topic of digital treatments for depres-
sion (ICBT) is reported in Table 4. Respondents were asked to indicate
whether their organisation in some way discussed or promoted digital
treatment for depression, and they replied by selecting “yes”, “partly”
or “no”. Considering the whole sample, the majority of organisations
(64%) reported that their organisation to some extent discussed or sup-
ported digital treatment. There were differences between stakeholder
categories (Kruskal-Wallis test, p b 0.001), characterised by lower activ-
ity among government bodies compared to care providers, researchers
and technology providers.
4.4. Acceptance of treatments
Stakeholders' acceptance of ICBT and BT respectively is presented in
Table 5. Organisations were asked to indicate whether in their opinion,
ICBT andBT couldbe recommended for the treatment of adult depression.
They replied by indicating “yes”, “no”, or “not applicable”. In the total
sample nearly half of respondents (47%) recommended standalone ICBT
formild depression. Formoderate and severe depression, the recommen-
dation-rates were 16% and 2% respectively. BT was recommended by the
majority of stakeholders for mild (70%) and moderate (57%) depression
andby 27% for severe depression. Therewere differences between groups
for both ICBT andBT, characterised by government bodies recommending
treatments to a lower degree than patient/service-users, caregivers and
research institutions (Kruskal-Wallis, p b 0.05–0.002). To further explore
the difference in acceptance for ICBT and BT, free text comments made
throughout the survey were assessed (also for items not discussed in
this paper). No commentsweremade onBT. Commentsmade onpossible
disadvantages on ICBT (n = 52) most frequently highlighted concerns
about clinical effect and aspects related to the absence of direct contact
between therapist and patient. Some examples of these comments are:
“impersonal, no direct eye contact”, “little emotion possible”, “the person-
al relationship with the therapist is lost, this is only possible via face-to-
face”, “lack of personal contact between patient and caregiver”, “does
not adequately address comorbidity/crisis/suicide risk”.
4.5. Expectance of treatments
Stakeholders' expectations regarding future integration of internet-
based treatments into conventional practices, in terms of incentives
and barriers, are reported in Table 6. According to all stakeholder groups
themost important reason for the implementation of ICBT into existing
care services was the reduced cost of treatment (33%). More rapid pa-
tient access to treatment was ranked the secondmost important incen-
tive among all stakeholder groups, with the exception of technology
businesses. Among all respondents the most important barrier for im-
plementation was the perception that their current care system was
not ready for service delivery of ICBT (21%). On the subgroup level the
responses differed, with stakeholder groups reporting limited internet
access/literacy (service-funders), lack of clinical effectiveness (patient/
service-users), and negative attitudes from patients and professionals
(government bodies) as the main barriers to implementation. There
were 23 comments on barriers. Caregivers provided most comments
(n= 15) and most frequently highlighted the negative aspects of ther-
apeutic alliance, clinical effect and patient commitment, and of imple-
mentation aspects (cost and budgeting, training of staff). Comments
from the other groupswere on the same topics and also highlighted po-
tential fear of competition among care giving professions and barriers in
infrastructure (internet access).
4.6. Factors associated to stakeholder attitudes
Stakeholders from frontrunner countries (Netherlands, Sweden and
United Kingdom) were found to self-report higher knowledge of ICBT
(M = 3.4, SD = 1.3) compared to stakeholders in other countries
(M=2.5, SD=1.7) (χ2, p ≤ 0.05). Organisations that reported discussing
digital treatments recommended ICBT and BT to a higher degree com-
pared to other organisations (χ2, p b 0.05–0.001), with the exception of
1
2
3
4
5
6
7
90%
0%
0%
0%
0%
0%
0%
0%
0%
80%
100%
r
percentage of the total sample
esponse-rate
Fig. 3. Response rates and percentage of the total sample for participating countries.
Table 2
Sample distribution, country and stakeholder level.
Country × stakeholder N, (%) Total sample
(N = 175)
Care provider
(N = 88)
Research Inst.
(N = 26)
Governing body
(N = 27)
Patient org.
(N = 14)
Tech. provider
(N = 9)
Funder
(N = 11)
Total sample 175 (100) 88 (50.3) 26 (14.9) 27 (15.4) 14 (8.0) 9 (5.1) 11 (6.3)
France 7 (4.0) 5 – – 2 – –
Germany 58 (33.1) 26 2 19 5 1 5
Netherland 17 (9.7) 10 5 – – 1 1
Poland 29 (16.6) 18 6 – 4 1 –
Spain 22 (12.6) 8 7 2 – 3 2
Sweden 24 (13.7) 13 1 4 1 3 2
Switzerland 13 (7.4) 7 3 2 – – 1
United Kingdom 5 (2.9) 1 2 – 2 – –
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ICBT for severe depression. German responders represented 33% of the
total sample and post-hoc tests (χ2, p b 0.05) showed that these organisa-
tions indicated signiﬁcant lower knowledge of ICBT (M=2.2), and lower
activity on digital treatments (45%) compared to the rest of the sample
(73%). No signiﬁcant differences were reported on the other topics.
5. Discussion
5.1. Summary of ﬁndings
This survey is the ﬁrst to report mental health stakeholder's attitudes
towards internet-based treatment (ICBT) and blended treatment (BT) for
adult depressiononEuropean level. The results showed that stakeholder's
who responded to the survey hadmoderate knowledge of ICBT and that a
majority (64%) discussed ICBT for depression or were in some other way
engaged with the topic. In terms of implementing ICBT into regular care
services, stakeholders considered improved cost-efﬁciency to be the
main advantage, and low feasibility of delivery within present care sys-
tems to be the primary barrier. ICBT andBT had higher level of acceptance
for milder forms of depression. A comparison of ICBT and BT showed that
the acceptancewas considerably higher for BT, and this resultwas consis-
tent for all stakeholder subgroups. On group level, it was also found that
government bodies indicated lesser knowledge and held more conserva-
tive attitudes towards ICBT compared to other stakeholders. Organisa-
tions from countries considered frontrunners in e-mental health
reported greater knowledge and more positive attitudes towards digital
treatments compared to other organisations.
5.2. Perceived advantages and barriers
Stakeholders' opinion of cost-effectiveness being the primary advan-
tage of ICBT is in line with advantages argued in scientiﬁc reports
(Andersson, 2014). This reﬂects the views of a range of stakeholders
in countries that are diverse in terms of care infrastructure and e-health.
Consequently, we may infer that there exists a broad agreement on the
rationale for delivery of digital treatments for depression. However,
many stakeholders also indicated that they did not expect current care
systems to be ready for an integration of ICBT—stakeholders expected
this to be primary barrier for implementation. On stakeholder group
level the results further revealed that expectations in some cases
seemed to be based on assumptions about other stakeholder groups.
For example, government bodies expected negative attitudes from pa-
tients and professionals to be a primary barrier for implementation.
This belief was supported by patient and caregiver reports of concerns
about limitations of internet use, ethical issues, and clinical effectiveness
of digital treatments. Moreover, the barriers considered by caregivers
and patient organisations are aspects that are to some extent the re-
sponsibility of researchers and technology providers. The results show
that there is a variation in perceived barriers between stakeholders, in-
dicating the need for future multi-stakeholder consultations on digital
treatments to avoid biased ﬁndings.
5.3. Result on acceptance of digital treatments
The acceptance of digital treatments varied with the severity of de-
pression. ICBT was perceived as suitable for mild depression only, even
though ICBT is well researched and has repeatedly shown to be an effec-
tive treatment for adult depression, even for severe stages (Meyer et al.,
2015; Richards and Richardson, 2012). The signiﬁcantly higher accep-
tance for BT (a relatively novel treatment approach yet to be evaluated
in clinical trials) indicates that the scepticism presented for ICBT may
not only be explained by lack of knowledge about both the ICBT concept
or the evidence-base for the approach. The reasons for the reported differ-
ence in the level of acceptance was not directly assessed in this survey,
however a review of free text comments made about ICBT throughout
the survey revealed opinions that are similar to those previously reported
bymental health professionals and students (Mitchell and Gordon, 2007;
Stallard et al., 2010). ICBT is perceived as ‘impersonal’, and concerns in
this survey were in most cases associated with the elimination of face-
to-face interaction between patient and therapist. The results indicate
that attitudes do not seem to change in pace with new digital develop-
ments, considering the increased everyday use of technology that is also
being widely applied in mental health settings (Patrick et al., 2016). The
comparison of ICBT and BT was made for the ﬁrst time in the E-COM-
PARED survey and the results are interesting. The readily acceptance for
BT raise the questions as to what extent do stakeholders attribute treat-
ment outcomes to objectives achieved during face to face meetings, and
if blended treatment approaches may present a middle path for digital
treatments that can be considered more acceptable. Of interest is also to
explore if the attitudes for ICBT compared to BT are similar for conditions
that are not associatedwith suicide risks (for example anxiety disorders).
5.4. Results on stakeholder group and country level
Explorations on sub-group level revealed that government bodies
self-reported signiﬁcantly less knowledge and activity on ICBT
Table 3
Stakeholders self-reported knowledge of internet-based treatment (ICBT) for adult depression, European level.
Knowledgea
(m, SD)
Total sample
(N = 168)
Care providers
(N = 88)
Research Inst.
(N = 26)
Governing body
(N = 21)
Patient org.
(N = 14)
Tech. providers
(N = 9)
Funders
(N = 10)
Reported knowledgeb 2.7 (1.6) 2.6 (1.6) 2.9 (1.4) 1.8 (1.9) 2.6 (1.4) 4.3 (1.0) 3.3 (1.3)
Rated on a six-point scale: 0 = no knowledge at all, to 5 = very good knowledge.
a Original wording: “To what extent does your organisation have knowledge about internet-based psychotherapy (referred to as online therapy and web-based treatment) as a
treatment tool for adult depression?”.
b Signiﬁcant differences among groups: p b 0.01. Respondents that indicated “does not apply” (total N = 7) were excluded.
Table 4
Stakeholders report on whether their organisation discuss or proclaim internet-based treatment (ICBT), European level.
Activitya (%) Total
(N = 159)
Care providers
(N = 82)
Research Inst.
(N = 22)
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 8)
Funders
(N = 10)
Activity
Yesb (full or partial)⁎ 64.2 64.6 90.9 33.3 61.5 100 50.0
No 20.8 24.4 4.5 29.2 23.1 0 20.0
Does not apply 15.1 11.0 4.5 37.5 15.4 0 30.0
Single-choice question.
⁎ Signiﬁcant differences among groups: p b 0.001.
a Original wording: “Is your organisation discussing and/or proclaiming internet-based psychotherapy as a future enhancement in mental health care?”.
b The original alternatives “yes” and “partly” have been merged into one category.
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compared to other stakeholder groups. Given that these organisations
hold high-level inﬂuence and several of the countries targeted in the
survey have recently revised their mental health policies to be more in-
clusive of e-health, the resultswere somewhat unexpected. Possibly the
responses from this group reﬂect that for many institutional bodies it is
a prerequisite that the effect of ICBT has been proven in real world set-
tings before moving forward with dissemination initiatives. Future dis-
semination activities may consider directing further attention to this
stakeholder group.
Patient organisations showed the least level of acceptance for ICBT as
treatment for depression, andwere concerned about the clinical and eth-
ical aspects of treatment. Thisﬁnding goes against previous reports of pa-
tients being more positive towards ICBT than clinicians (Andersson,
2014). A recent study, which explored patients' and clinicians' accep-
tance towards online components in treatment also showed that patients
weremore accepting than clinicians (van der Vaart et al., 2014). The rea-
son for the ﬁndings of the E-COMPARED survey is unknown, but possible
explanations may be that the majority of patient organisations came
fromGermany and Poland (where ICBT is not widely known) or that pa-
tient representatives and not actual patients participated in this survey.
Stakeholders from countries with more integrated e-mental health
services (Netherlands, Sweden, United Kingdom) had more knowledge
of ICBT and were more positive towards ICBT. In these countries, cogni-
tive behaviour therapy is the dominant orientation of psychotherapy,
and it is possible that this might interplay with participants' attitudes.
In contrast, for example France has a strong tradition of psychodynamic
therapies, and French stakeholders rated the relevance and advantage
of ICBT as low (result not included in this paper).
6. Strengths and limitations
One of themain strengths of the surveywas the purposive sample of
stakeholders representing the current status in Europe in terms of care
infrastructure and e-health integration. The surveymanaged to recruit a
large number of organisations that represented all targeted stakeholder
categories and countries. A high proportion of participants completed
the full survey (82%). Several limitations of the survey need to be con-
sidered when interpreting the results. The sample can be considered a
convenience sample (introducing recruitment and response biases),
and the response-rate variedwidely between countries and stakeholder
Table 5
Stakeholders recommendation of digital treatments, European level.
Recommend (%) Total
(N = 159)
Care providers
(N = 82)
Research Inst.
(N = 22)
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 8)
Funders
(N = 10)
Standalone Internet-based treatmenta
Mild depression* 46.5 39.0 72.7 33.3 38.5 75.0 70.0
Moderate depression* 15.7 13.4 31.8 12.5 0 37.5 10.0
Severe depression** 1.9 2.4 0 0 0 12.5 0
Blended treatmentb
Mild depression 69.8 72.0 81.8 45.8 76.9 75.0 70.0
Moderate depression** 57.2 54.9 72.7 29.2 76.9 70.0 70.0
Severe depression** 27.0 22.0 40.9 8.3 38.5 50.0 50.0
Single-choice question: “yes”, “no”, “does not apply”.
Signiﬁcant differences among groups: * = p b 0.05, ** = p b 0.01.
a Original wording: “Do you/Would your organisation recommend stand-alone treatment full psychotherapy program for computer/tablet/smartphone, with online educational ma-
terial and communication with health care professional?”.
b Original wording: “Does/Would your organisation recommend traditional face-to-face treatmentwith the addition of a web-based platform and digital tools for support, with the aim
of reducing the number of face-to-face sessions while maintaining the same treatment quality?”.
Table 6
Incentive/barrier for an implementation of standalone internet-based treatment (ICBT) into care systems, European level.
Incentive/barrier (%) Total
(N = 155)
Care providers
(N = 80)
Research Inst.
(N = 21)
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 7)
Funders
(N = 10)
Incentivea
Reduced cost of treatment 32.9 27.5 47.6 33.3 38.5 42.9 30.0
Patient access to treatment 21.9 25.0 14.3 20.8 30.8 0 20.0
Patient empowerment 7.1 10.0 0 4.2 7.7 14.3 0
Reduced treatment gap 6.5 6.3 14.3 4.2 0 14.3 0
Clinical effect corresponds to TAUb 5.8 7.5 9.5 4.2 0 0 0
Patient convenience 5.2 8.8 0 0 7.7 0 0
None 3.9 3.8 0 4.2 7.7 0 10.0
Other 2.6 0 4.8 0 0 14.3 20.0
Patient adherence 0.6 0 4.8 0 0 0 0
Do not know/does not apply 13.5 11.3 4.8 29.2 7.7 14.3 20.0
Barriera
Health care system not ready 20.6 22.5 23.8 12.5 23.1 28.6 10.0
Clinical effect inferior to TAUb 14.8 16.3 19.0 8.3 30.8 0 0
Professional/patient attitude (neg) 12.3 8.8 14.3 20.8 7.7 14.3 20.0
Limited internet literacy & access 12.2 11.3 14.3 4.2 7.7 14.3 40.0
Other 9.0 10.0 9.5 8.3 0 14.3 10.0
Limited online safety 8.4 10.0 9.5 8.3 7.7 0 0
Not ethical 3.9 2.5 0 4.2 23.1 0 0
Not time/cost effective 3.9 5.0 0 4.2 0 0 0
Cultural barriers 2.6 3.8 4.8 0 0 0 0
None 0.6 1.3 0 0 0 0 0
Do not know/does not apply 11.6 8.8 4.8 29.2 0 28.6 20.0
a Original wording: “What does your organisation expect to be themost important incentive/barrier for integrating internet-based psychotherapy as a stand-alone treatment for adult
depression in your country's health care system?”.
b TAU= treatment as usual. Bold prints identify the most frequently reported answer.
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groups. There was no higher limit of participants in recruitment guide-
lines, which for example is reﬂected in the high proportion of German
responders. Post-hoc test showed that German responders differed
fromothers on the topic of knowledge and activity. Alongwith the over-
all limitations in sampling and distribution this may affect the certainty
of obtained results. Moreover, many organisations did not accept the
invitation (response-rate 23%) and no information on reasons for
non-responding was collected. It should also be mentioned that al-
though efforts were made to ensure that survey questions were
interpreted the same way across countries and stakeholder catego-
ries, and that respondents were repeatedly instructed to answer on
behalf of their organisation, there were no formal procedures to con-
trol that this was achieved.
7. Implications and future directions
The relevance of e-mental health in relation to the treatment gap is
stated in scientiﬁc and legislative reports. It is therefore necessary to as-
sess the views of stakeholders that are involved/affected by mental
health care provisions. The E-COMPARED survey presents its ﬁndings
on European stakeholders' opinions (valid for diverse European set-
tings) about digital treatments in terms of their knowledge, acceptance
and expectations. The results obtained on knowledge and activity are in
line with what we expected. These ﬁndings highlight the need to dis-
seminate not only results of clinical and cost effectiveness but also to
share best practices and clearly communicate for whom, when and
how digital treatments might be applied. The results on acceptance for
different treatment approaches (ICBT and BT) provide new information
on what may inﬂuence stakeholders' attitudes towards technology in
treatment. The ﬁndings on blended treatment are interesting, and fu-
ture research can further investigate whether a gradual integration of
technology into clinical practice (i.e., blended treatment) might ﬁt
with the attitudes and expectations of mental healthcare stakeholders.
The results of the E-COMPARED survey can serve as the foundation for
future stakeholder dissemination activities in terms of what informa-
tion should be provided, and what topics may be perceived as relevant
by different stakeholder categories.
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